Literature DB >> 33826054

Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population.

Paul A Gurbel1, Kevin P Bliden2, Amit Rout2, Nicole Rapista2, Naval Walia2, Rahul Chaudhary3, Gordon Ens4, Malina Traianova5, Jaime S Barnes6, Udaya S Tantry2.   

Abstract

Entities:  

Year:  2021        PMID： 33826054     DOI： 10.1007/s11239-021-02435-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  1 in total

1.  Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients.

Authors:  Philbert Y Van; S David Cho; Samantha J Underwood; Melanie S Morris; Jennifer M Watters; Martin A Schreiber
Journal:  J Trauma       Date:  2009-06
  1 in total
  4 in total

1.  Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.

Authors:  Bingwen Eugene Fan; Kollengode Ramanathan; Christina Lai Lin Sum; Dheepa Christopher; Stephrene Seok Wei Chan; Gek Hsiang Lim; Chwee Fang Bok; Shiun Woei Wong; David Chien Lye; Barnaby Edward Young; Jia Yan Lim; Rui Min Lee; Shu Ping Lim; Hwee Tat Tan; Mui Kia Ang; Soon Lee Lau; Ponnudurai Kuperan; Kiat Hoe Ong; Yew Woon Chia
Journal:  J Thromb Thrombolysis       Date:  2021-09-28       Impact factor: 5.221

2.  Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism.

Authors:  Martin R Prince; Hreedi Dev; Elizabeth G Lane; Daniel J Margolis; Maria T DeSancho
Journal:  J Thromb Thrombolysis       Date:  2022-06-10       Impact factor: 5.221

3.  International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests.

Authors:  Paul A Gurbel; Udaya S Tantry; Robert F Storey
Journal:  J Thromb Thrombolysis       Date:  2021-05-22       Impact factor: 2.300

Review 4.  Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.

Authors:  Diana A Gorog; Robert F Storey; Paul A Gurbel; Udaya S Tantry; Jeffrey S Berger; Mark Y Chan; Daniel Duerschmied; Susan S Smyth; William A E Parker; Ramzi A Ajjan; Gemma Vilahur; Lina Badimon; Jurrien M Ten Berg; Hugo Ten Cate; Flora Peyvandi; Taia T Wang; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2022-01-13       Impact factor: 49.421
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.